← Back to Discover
Virtus Investment Advisers, Inc.
Period ended Sep 30, 2026 · Latest filing Nov 12, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Sep 30, 2026: $452,825,567
More quarters will appear as history becomes available.
Top holdings
Top 10 at Sep 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- MODERNA INC · COM · 60770K107 · shares: $6,503,089
- IOVANCE BIOTHERAPEUTICS INC · COM · 462260100 · shares: $6,122,305
- REGENERON PHARMACEUTICALS · COM · 75886F107 · shares: $4,162,902
- GILEAD SCIENCES INC · COM · 375558103 · shares: $4,111,842
- AMGEN INC · COM · 031162100 · shares: $4,040,595
- VERTEX PHARMACEUTICALS INC · COM · 92532F100 · shares: $4,008,907
- OMEROS CORP · COM · 682143102 · shares: $3,673,939
- INCYTE CORP · COM · 45337C102 · shares: $3,661,979
- BIOMARIN PHARMACEUTICAL INC · COM · 09061G101 · shares: $3,646,980
- VERASTEM INC · COM NEW · 92337C203 · shares: $3,309,331
Reported holdings
458 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| GOLDMAN SACHS BDC INC | SHS | 38147U107 | — | 57,361 shares | $521,411 |
| ORIC PHARMACEUTICALS INC | COM | 68622P109 | — | 38,372 shares | $516,871 |
| 4D MOLECULAR THERAPEUTICS IN | COM | 35104E100 | — | 35,938 shares | $514,273 |
| CRESCENT CAP BDC INC | COM | 225655109 | — | 55,526 shares | $509,729 |
| SELLAS LIFE SCIENCES GROUP I | COM NEW | 81642T209 | — | 40,528 shares | $498,900 |
| ADLAI NORTYE GROUP LTD | SPONSORED ADS | 00704R109 | — | 30,749 shares | $491,984 |
| CARLYLE SECURED LENDING INC | COM | 872280102 | — | 45,915 shares | $490,831 |
| DEFINIUM THERAPEUTICS INC | COM SHS | 24477V105 | — | 12,822 shares | $488,005 |
| REPLIMUNE GROUP INC | COM | 76029N106 | — | 35,736 shares | $473,145 |
| PALMER SQUARE CAPITAL BDC IN | COM SHS | 69702V107 | — | 47,801 shares | $472,752 |
| MIDCAP FINANCIAL INVSTMNT CO | COM NEW | 03761U502 | — | 54,027 shares | $472,196 |
| OAKTREE SPECIALTY LENDING | COM | 67401P405 | — | 39,539 shares | $470,514 |
| BLACKROCK FLOATING RATE INCO | COM | 09255X100 | — | 44,465 shares | $468,661 |
| NUVEEN CR STRATEGIES INCOME | COM SHS | 67073D102 | — | 98,453 shares | $467,652 |
| BAIN CAP SPECIALTY FIN INC | COM STK | 05684B107 | — | 42,269 shares | $466,650 |
| ACHIEVE LIFE SCIENCE INC | COM | 004468500 | — | 57,488 shares | $465,078 |
| BLUE OWL CAPITAL CORPORATION | COM | 69121K104 | — | 43,678 shares | $458,182 |
| NUVEEN FLOATING RATE INCOME | COM | 67072T108 | — | 61,565 shares | $458,044 |
| SPYGLASS PHARMA INC | COM SHS | 85220G109 | — | 17,209 shares | $447,434 |
| BLACKROCK FLOATING RATE INC | COM | 091941104 | — | 42,550 shares | $447,201 |
| NURIX THERAPEUTICS INC | COM | 67080M103 | — | 18,722 shares | $443,899 |
| KKR INCOME OPPORTUNITIES FD | COM | 48249T106 | — | 42,398 shares | $436,699 |
| ZENAS BIOPHARMA INC | COM | 98937L105 | — | 16,027 shares | $432,248 |
| LB PHARMACEUTICALS INC | COM SHS | 50180M108 | — | 11,166 shares | $428,551 |
| REVOLUTION MEDICINES INC | COM | 76155X100 | — | 2,062 shares | $423,246 |
| MONOPAR THERAPEUTICS INC | COM NEW | 61023L207 | — | 5,309 shares | $422,968 |
| VOR BIOPHARMA INC | COM NEW | 929033207 | — | 22,098 shares | $421,630 |
| BLACKSTONE SECD LENDING FD | COMMON STOCK | 09261X102 | — | 17,549 shares | $420,825 |
| IDEAYA BIOSCIENCES INC | COM | 45166A102 | — | 10,950 shares | $420,699 |
| BLACKROCK DEBT STRATEGIES FD | COM NEW | 09255R202 | — | 46,434 shares | $417,906 |
| RECURSION PHARMACEUTICALS IN | CL A | 75629V104 | — | 100,741 shares | $416,060 |
| VIR BIOTECHNOLOGY INC | COM | 92764N102 | — | 36,856 shares | $412,050 |
| KYMERA THERAPEUTICS INC | COM | 501575104 | — | 3,681 shares | $411,499 |
| FIDUS INVT CORP | COM | 316500107 | — | 21,092 shares | $406,443 |
| GOLUB CAP BDC INC | COM | 38173M102 | — | 32,143 shares | $405,966 |
| JANUX THERAPEUTICS INC | COM | 47103J105 | — | 23,402 shares | $404,387 |
| PALVELLA THERAPEUTICS INC NE | COM | 697947109 | — | 2,916 shares | $402,204 |
| VERADERMICS INC | COMMON STOCK | 922967104 | — | 3,303 shares | $400,423 |
| VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | — | 19,409 shares | $399,631 |
| EATON VANCE FLOATING RATE IN | COM | 278279104 | — | 36,612 shares | $391,016 |
| IMMIX BIOPHARMA INC | COM | 45258H106 | — | 37,554 shares | $390,749 |
| EATON VANCE SR INCOME TR | SH BEN INT | 27826S103 | — | 80,499 shares | $390,420 |
| BELITE BIO INC | SPONSORED ADS | 07782B104 | — | 2,297 shares | $390,077 |
| CANDEL THERAPEUTICS INC | COM | 137404109 | — | 37,072 shares | $387,032 |
| RELAY THERAPEUTICS INC | COM | 75943R102 | — | 21,427 shares | $386,757 |
| GENERATE BIOMEDICINES INC | COM SHS | 370920100 | — | 25,633 shares | $385,008 |
| SLR INVESTMENT CORP | COM | 83413U100 | — | 33,187 shares | $384,637 |
| EATON VANCE SR FLTNG RTE TR | COM | 27828Q105 | — | 36,866 shares | $383,406 |
| SUMMIT THERAPEUTICS INC | COM | 86627T108 | — | 22,651 shares | $383,028 |
| VAXCYTE INC | COM | 92243G108 | — | 6,686 shares | $380,433 |
| HERCULES CAPITAL INC | COM | 427096508 | — | 22,578 shares | $379,536 |
| NUVEEN CHURCHILL DIRECT LEND | COM SHS | 67090S108 | — | 33,655 shares | $378,282 |
| ORUKA THERAPEUTICS INC | COM | 687604108 | — | 4,540 shares | $378,137 |
| CG ONCOLOGY INC | COM | 156944100 | — | 5,328 shares | $377,702 |
| ALTO NEUROSCIENCE INC | COM SHS | 02157Q109 | — | 14,780 shares | $377,333 |
| BIOHAVEN LTD | COM | G1110E107 | — | 28,132 shares | $375,562 |
| GLADSTONE CAP CORP | COM NEW | 376535878 | — | 19,501 shares | $375,004 |
| IMMUNOME INC | COM | 45257U108 | — | 17,265 shares | $371,370 |
| MORGAN STANLEY DIRECT LENDIN | COM SHS | 61774A103 | — | 27,144 shares | $369,973 |
| EDGEWISE THERAPEUTICS INC | COM | 28036F105 | — | 9,111 shares | $369,907 |
| ARES DYNAMIC CR ALLOCATION F | COM | 04014F102 | — | 31,928 shares | $367,172 |
| MEIRAGTX HLDGS PLC | COM | G59665102 | — | 33,090 shares | $363,990 |
| DESIGN THERAPEUTICS INC | COM | 25056L103 | — | 28,927 shares | $363,612 |
| SIXTH STREET SPECIALTY LENDI | COM | 83012A109 | — | 20,051 shares | $361,319 |
| GLADSTONE INVT CORP | COM | 376546107 | — | 23,144 shares | $361,046 |
| VIKING THERAPEUTICS INC | COM | 92686J106 | — | 11,038 shares | $359,839 |
| BARINGS BDC INC | COM | 06759L103 | — | 41,644 shares | $358,971 |
| REGENXBIO INC | COM | 75901B107 | — | 47,648 shares | $358,789 |
| MAZE THERAPEUTICS INC | COM | 578784100 | — | 13,195 shares | $358,640 |
| INVIVYD INC | COM | 00534A102 | — | 412,122 shares | $358,587 |
| ARBUTUS BIOPHARMA CORP | COM | 03879J100 | — | 74,492 shares | $356,072 |
| CULLINAN THERAPEUTICS INC | COM | 230031106 | — | 23,163 shares | $355,552 |
| GH RESEARCH PLC | ORDINARY SHARES | G3855L106 | — | 15,025 shares | $352,787 |
| MSC INCOME FUND INC | COM | 55374X208 | — | 29,774 shares | $350,440 |
| SPYRE THERAPEUTICS INC | COM NEW | 00773J202 | — | 3,928 shares | $349,710 |
| PRIME MEDICINE INC | COM | 74168J101 | — | 114,355 shares | $349,355 |
| ALTIMMUNE INC | COM NEW | 02155H200 | — | 121,584 shares | $347,730 |
| SCHOLAR ROCK HLDG CORP | COM | 80706P103 | — | 7,183 shares | $347,083 |
| PRAXIS PRECISION MEDICINES I | COM NEW | 74006W207 | — | 1,190 shares | $346,564 |
| CAPITAL SOUTHWEST CORP | COM | 140501107 | — | 14,966 shares | $346,164 |
| SEPTERNA INC | COM | 81734D104 | — | 8,827 shares | $345,401 |
| SANA BIOTECHNOLOGY INC | COM | 799566104 | — | 118,408 shares | $345,159 |
| INHIBRX BIOSCIENCES INC | COM | 45720N103 | — | 3,442 shares | $344,475 |
| ARCUS BIOSCIENCES INC | COM | 03969F109 | — | 13,333 shares | $344,391 |
| DIANTHUS THERAPEUTICS INC | COM | 252828108 | — | 3,867 shares | $340,489 |
| MINERALYS THERAPEUTICS INC | COM | 603170101 | — | 13,435 shares | $337,622 |
| BLACKROCK LTD DURATION INCOM | COM SHS | 09249W101 | — | 29,103 shares | $334,393 |
| ERASCA INC | COM | 29479A108 | — | 22,586 shares | $331,111 |
| BLACKSTONE SENI FLTN RAT 202 | COM | 09256U105 | — | 25,549 shares | $330,860 |
| AVALO THERAPEUTICS INC | COM NEW | 05338F306 | — | 21,500 shares | $329,595 |
| BLACKSTONE STRATEGIC CRED 20 | COM SHS BEN IN | 09257R101 | — | 29,317 shares | $329,523 |
| CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | — | 10,148 shares | $328,897 |
| REZOLUTE INC | COM NEW | 76200L309 | — | 79,333 shares | $328,439 |
| PHARVARIS N V | COM | N69605108 | — | 10,330 shares | $327,668 |
| COMPASS PATHWAYS PLC | SPONSORED ADS | 20451W101 | — | 26,269 shares | $326,786 |
| DAMORA THERAPEUTICS INC | COM SHS | G2646Y104 | — | 15,271 shares | $324,967 |
| ASSEMBLY BIOSCIENCES INC | COM NEW | 045396207 | — | 13,821 shares | $324,655 |
| ARVINAS INC | COM | 04335A105 | — | 41,865 shares | $323,826 |
| NEKTAR THERAPEUTICS | COM NEW | 640268306 | — | 5,344 shares | $323,552 |
| ARES CAPITAL CORP | COM | 04010L103 | — | 16,902 shares | $322,828 |